Moreover, Gal was investigated either as monotherapy or in combination with standard anti-tumor regimens in patients with cancer, including glioblastoma, pancreatic cancer, and hepatocellular carcinoma. The gene discussed is GAL; the disease is hepatocellular carcinoma.